We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$21.5B
AUM Growth
+$1.77B
Cap. Flow
+$1.09B
Cap. Flow %
5.05%
Top 10 Hldgs %
53.56%
Holding
4,787
New
28
Increased
1,004
Reduced
647
Closed
2,866

Sector Composition

Rank Sector Weight
1 Financials 5.08%
2 Technology 4.32%
3 Energy 3.31%
4 Communication Services 2.33%
5 Healthcare 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
1701
Fate Therapeutics
FATE
$275M
$111K ﹤0.01%
28,000
AAOI icon
1702
CALL
Applied Optoelectronics
AAOI
$6.14B
$108K ﹤0.01%
10,000
+8,200
+456% +$580K
CIF
1703
DELISTED
MFS Intermediate High Income Fund
CIF
$108K ﹤0.01%
+36,726
New +$106K
RRD
1704
DELISTED
RR Donnelley & Sons Co.
RRD
$108K ﹤0.01%
10,523
-750
-7% -$7.77K
NWG icon
1705
NatWest
NWG
$69.9B
$107K ﹤0.01%
13,653
+10,009
+275% +$72.6K
KMDA icon
1706
Kamada
KMDA
$404M
$106K ﹤0.01%
22,000
+17,000
+340% +$82.9K
BCIC
1707
BCP Investment Corp
BCIC
$88.3M
$105K ﹤0.01%
2,887
-100
-3% -$3.43K
WPG
1708
DELISTED
Washington Prime Group Inc.
WPG
$105K ﹤0.01%
1,399
-20
-1% -$1.55K
SCU
1709
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$104K ﹤0.01%
3,221
-223
-6% -$6.6K
CTIC
1710
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$104K ﹤0.01%
32,573
+30,000
+1,166% +$100K
EGIO
1711
DELISTED
Edgio, Inc. Common Stock
EGIO
$102K ﹤0.01%
643
+5
+0.8% +$703
SGYP
1712
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$99K ﹤0.01%
34,205
-117,500
-77% -$401K
GAIN icon
1713
Gladstone Investment Corp
GAIN
$642M
$98K ﹤0.01%
10,300
+8,589
+502% +$80.7K
ACGN
1714
DELISTED
Aceragen Inc
ACGN
$97K ﹤0.01%
321
CDE icon
1715
Coeur Mining
CDE
$15.1B
$96K ﹤0.01%
10,500
-2,000
-16% -$17K
ABEV icon
1716
Ambev
ABEV
$47.9B
$94K ﹤0.01%
14,277
+2,442
+21% +$15.1K
OCSL icon
1717
Oaktree Specialty Lending
OCSL
$1.05B
$94K ﹤0.01%
5,719
-1,904
-25% -$30.4K
RVSB icon
1718
Riverview Bancorp
RVSB
$107M
$94K ﹤0.01%
11,185
ASG
1719
Liberty All-Star Growth Fund
ASG
$321M
$93K ﹤0.01%
17,843
+368
+2% +$1.84K
WPRT
1720
Westport Fuel Systems
WPRT
$31.9M
$92K ﹤0.01%
2,827
SRC
1721
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$91K ﹤0.01%
2,361
CSR
1722
Centerspace
CSR
$952M
$90K ﹤0.01%
1,473
-436
-23% -$26.7K
OCUL icon
1723
Ocular Therapeutix
OCUL
$1.83B
$90K ﹤0.01%
14,600
+6,800
+87% +$43.8K
SVM
1724
Silvercorp Metals
SVM
$2.02B
$88K ﹤0.01%
32,700
-550
-2% -$1.59K
CFMS
1725
DELISTED
Conformis, Inc. Common Stock
CFMS
$88K ﹤0.01%
1,000

Similar funds

Creative Planning's Q3 2017 Portfolio in Review

As of Q3 2017, Creative Planning held 4,787 positions worth $21.5B, up 9% from $19.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Creative Planning deployed $1.09B of net new capital in Q3 2017, opening 28 new positions and adding to 1,004 existing holdings. Its largest new stake was Global X MSCI China Consumer Discretionary ETF: 53,331 shares worth $916K.

By sector, the portfolio is most concentrated in Financials at 5.1% of assets, down from 5.1% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $80.5M trimmed.

  • Creative Planning's largest Q3 2017 buy was Global X MSCI China Consumer Discretionary ETF: 53,331 shares worth $916K.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $139M increase.
  • Creative Planning's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $80.5M.
  • Creative Planning fully exited Oneok Partners LP in Q3 2017, selling an estimated $49.5M.
  • Creative Planning's ten largest holdings make up 54% of its $21.5B portfolio in Q3 2017.
  • Creative Planning opened 28 new positions and closed 2,866 in Q3 2017.
  • Creative Planning's portfolio value rose 9% quarter-over-quarter to $21.5B.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.